Cite
Liu C, Huang X, Werner M, et al. Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy. Front Immunol. 2017;8:323doi: 10.3389/fimmu.2017.00323.
Liu, C., Huang, X., Werner, M., Broering, R., Ge, J., Li, Y., Liao, B., Sun, J., Peng, J., Lu, M., Hou, J., & Zhang, X. (2017). Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy. Frontiers in immunology, 8323. https://doi.org/10.3389/fimmu.2017.00323
Liu, Chao, et al. "Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy." Frontiers in immunology vol. 8 (2017): 323. doi: https://doi.org/10.3389/fimmu.2017.00323
Liu C, Huang X, Werner M, Broering R, Ge J, Li Y, Liao B, Sun J, Peng J, Lu M, Hou J, Zhang X. Elevated Expression of Chemokine CXCL13 in Chronic Hepatitis B Patients Links to Immune Control during Antiviral Therapy. Front Immunol. 2017 Mar 23;8:323. doi: 10.3389/fimmu.2017.00323. eCollection 2017. PMID: 28386259; PMCID: PMC5362616.
Copy
Download .nbib